TEVA
Teva Pharmaceutical Industries
Earnings and EPS analysis
- Stocks
- Healthcare
- NYSE: TEVA
- Earnings
EPS in 2026 (TTM): $1.37
Last Report Period Date: Mar 31, 2026
As of June 2026, according to Teva Pharmaceutical Industries's latest financial report, the company's current EPS (TTM) is $1.37. In 2025, the company recorded an earnings per share (EPS) of $1.23, which represents an increase compared to its EPS of -$1.45 in 2024. Teva Pharmaceutical Industries's earnings per share for the quarterly report ending on Mar 31, 2026 was $0.32.
TEVA earnings history
The annual EPS in 2025 was $1.23, an increase of 184.8% from -$1.45 in 2024. For the quarter ending Mar 31, 2026, the EPS was $0.32, showing a 68.4% increase from the same quarter last year. The trailing twelve months (TTM) EPS as of March 2026 is $1.37. In 2024, the annual EPS was -$1.45, showing a decrease of 190% from 2023.
TEVA earnings chart
TEVA EPS growth history
Over the last 12 months, Teva Pharmaceutical Industries has registered an EPS growth of 68.4% (YoY, quarterly). When measured over a ten-year period, TEVA's average EPS growth rate was -3.9%.
TEVA Earnings Waterfall
TEVA Earnings vs Peers
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| PFE Pfizer Inc | 18.87 | -3.5% | -37.4% | -3.7% |
| NVS Novartis AG | 21.85 | 21.8% | 31.2% | 15.2% |
| TEVA Teva Pharmaceutical Industries Ltd | 24.24 | 184.8% | N/A | N/A |
| AZN Astrazeneca plc | 26.98 | 45.4% | 46% | 22% |
| MRK Merck & Co Inc | 33.5 | 8% | 8.4% | 21.2% |
All data is based on quarterly TTM periods, unless otherwise specified.